m+Medelevator.RU
← Поиск публикаций
Biology · 2026

Baicalin Modulates Hepatic Lipid Metabolism and Improves Intestinal Health in White-Feathered Broilers.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Li Junxin, Huang Xiaowei, Li Yana, Zheng Yu, Zhang Shizhong, Zheng Bohan, Li Qinjin, Huang Xiaohong, Lin Zhaoyan

Аннотация

Liver and intestinal health govern the production performance of broilers. Baicalin (BA) is a flavonoid extracted from the dried roots of Scutellaria baicalensis and possesses a wide range of biological activity. In this study, 66 one-day-old white-feathered broilers were selected and randomly divided into two groups. Broilers in the control group were fed a basal diet, whereas the BA group received the basal diet supplemented with 100 mg/kg BA. The results showed that BA supplementation markedly elevated the antioxidant capacity of the serum and liver (p < 0.05). Meanwhile, the villus height/crypt depth ratio and the activity of intestinal digestive enzymes were significantly higher in the BA group (p < 0.01). Transcriptomics, RT-qPCR, and Western blot assays revealed that BA-mediated effects were associated with the hepatic PPARα signaling pathway and the regulation of lipid metabolism. Furthermore, a combined analysis encompassing intestinal microbiota 16S rRNA sequencing and plasma metabolomics revealed that the BA-induced enrichment of multiple bacterial taxa, such as Lachnospiraceae, may modulate butyrate metabolism and circulating metabolites including isoleucyl-glutamate in broilers. In conclusion, dietary BA supplementation improved the hepatic and intestinal health of white-feathered broilers, reshaped the intestinal microbiota composition, and altered the plasma metabolite profile, with these benefits linked to the PPARα signaling pathway.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты